Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea in Beta-Thalassemia Intermedia
NCT00001958Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Dec 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydroxyurea in beta-thalassemia intermedia, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoints: Hemoglobin Level at 3 years, Hematocrit Level at 3 years and 2 more. Started Dec 1999; status: completed.
02
Drugs
hydroxyurea
03
Conditions
beta-thalassemia intermedia
Beyond the preview
Go deeper on NCT00001958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001958.